TPIDB > Principal Investigator
Principal Investigator
更新時間：2023-09-19
戴春暉TAI, CHUN-HWEI
- Principal Investigator
- Clinical Trial Experience (year) 17 years 9 個月
Publication
11Publications
1
Tai CH, Pan MK, Tseng SH, Wang TR, Kuo CC. Hyperpolarization of the subthalamic nucleus alleviates hyperkinetic movement disorders. Sci Rep. 2020 May 19;10(1):8278. doi: 10.1038/s41598-020-65211-w. Erratum in: Sci Rep. 2020 Jun 12;10(1):9840. PMID: 32427942; PMCID: PMC7237462.
2
Su FT, Tai CH, Tan CH, Hwang WJ, Yu RL. The Development of the Social Functioning Scale for Patients with Parkinson's Disease. J Parkinsons Dis. 2020;10(3):1143-1151. doi: 10.3233/JPD-201930. PMID: 32444559.
3
Correction to: Feasibility of Smartphone-Based Gait Assessment for Parkinson's Disease (Journal of Medical and Biological Engineering, (2020), 40, 4, (582-591), 10.1007/s40846-020-00551-6)
4
Tai CH, Hwu WL, Wu RM, Tseng SH. Modified Frameless Stereotactic System for Intracerebral Delivery of Viral Vector in Young Children. Oper Neurosurg (Hagerstown). 2020 Feb 1;18(2):166-174. doi: 10.1093/ons/opz119. PMID: 31214706.
5
Lee YY, Li MH, Tai CH, Luh JJ. Corticomotor Excitability Changes Associated With Freezing of Gait in People With Parkinson Disease. Front Hum Neurosci. 2020 May 21;14:190. doi: 10.3389/fnhum.2020.00190. PMID: 32508609; PMCID: PMC7253638.
6
Tai CH, Pan MK, Tseng SH, Wang TR, Kuo CC. Hyperpolarization of the subthalamic nucleus alleviates hyperkinetic movement disorders. Sci Rep. 2020 May 19;10(1):8278. doi: 10.1038/s41598-020-65211-w. Erratum in: Sci Rep. 2020 Jun 12;10(1):9840. PMID: 32427942; PMCID: PMC7237462.
7
Lee YY, Tai CH, Fisher BE. Context-Dependent Behavior in Parkinson's Disease With Freezing of Gait. Neurorehabil Neural Repair. 2019 Dec;33(12):1040-1049. doi: 10.1177/1545968319883878. Epub 2019 Nov 6. PMID: 31690228.
8
Lin CH, Chen PL, Tai CH, Lin HI, Chen CS, Chen ML, Wu RM. A clinical and genetic study of early-onset and familial parkinsonism in taiwan: An integrated approach combining gene dosage analysis and next-generation sequencing. Mov Disord. 2019 Apr;34(4):506-515. doi: 10.1002/mds.27633. Epub 2019 Feb 20. PMID: 30788857; PMCID: PMC6594087.
9
Tai CH, Bellesi M, Chen AC, Lin CL, Li HH, Lin PJ, Liao WC, Hung CS, Schwarting RK, Ho YJ. A new avenue for treating neuronal diseases: Ceftriaxone, an old antibiotic demonstrating behavioral neuronal effects. Behav Brain Res. 2019 May 17;364:149-156. doi: 10.1016/j.bbr.2019.02.020. Epub 2019 Feb 12. PMID: 30768995.
10
Ho YJ, Shen MS, Tai CH, Li HH, Chen JH, Liao WC, Chiu PY, Lee IY, Lin CL, Hung CS. Use of Ceftriaxone in Treating Cognitive and Neuronal Deficits Associated With Dementia With Lewy Bodies. Front Neurosci. 2019 May 24;13:507. doi: 10.3389/fnins.2019.00507. PMID: 31178684; PMCID: PMC6543807.
1
2
